
|Articles|September 3, 2007
New HIV drug first to target CCR5 receptor
A drug with a new mechanism of action is always a welcome addition in the fight against HIV. Maraviroc was recently approved by the FDA and is the first of the chemokine receptor 5 antagonists to enter the market.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Oral Semaglutide Show Promise as New Benchmark for Diabetes Care, Cardiovascular Protection
2
Limited Clinical Data Impact Cannabis Integration Into Standard Care | ASHP Midyear 2025
3
Opioid Overdose Deaths Fall by 34% in 2025 | ASHP Midyear 2025
4
Delgocitinib Improves Patients’ Chronic Hand Eczema
5




























































































































